Jeffrey R. Starke, MD
Approximately 1 million treatment courses of new tuberculosis medicines designed for easy administration in children have been ordered by 93 countries since they were first introduced in 2016, according to the nonprofit organization TB Alliance.
“Strategic investments in TB treatment for children have corrected a dire market failure and enabled the rapid, widespread introduction of child-friendly TB medicines around the world,” Mel Spigelman, MD, president and CEO of TB Alliance, told Infectious Diseases in Children.
This activity is supported by an educational grant from Merck & Co., Inc.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.